NEW YORK, Oct. 14 (GenomeWeb News) - R&D services firm Commonwealth Biotechnologies said today that it has signed $1.5 million in new biodefense-related contracts for October.

The company said that the contracts will support further development and validation of detection assays based on its mass spectrometry and DNA sequence analysis platforms.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.